Helga Ruebsamen-schaeff
Business
Merck
Germany
Biography
Education: 1967-71 Studies of Chemistry, University of Münster, degree: Diploma 1973 Dr. rer. Nat. degree, University of Münster Professional career: 1973-1979 Post-Doc, University of Münster, Cornell University, Ithaca, NY, USA, Gießen 1979-1982 Habilitation scholar (Deutsche Forschungsgemeinschaft), University of Cologne, Paul-Ehrlich Institut Frankfurt/ Main 1982-1986 Head of division, Institute for Biomedical Research Georg-Speyer-Haus, Frankfurt/Main 1983 Habilitation, University of Frankfurt/Main 1983 and 1985 Guest scienstist, Harvard University, Cambridge, MA, USA 1987-1993 Scientific and Managing Director, Institute for Biomedical Research Georg-Speyer-Haus, Frankfurt/Main since 1988 Professor (Biochemistry and Virology), University of Frankfurt/Main 1994-2001 Vice President, head of institute of virology, Bayer AG, Leverkusen 2001-2006 Senior Vice President, head of anti-infective research, Bayer AG, Leverkusen 2006-2015 Managing Director (CEO), AiCuris GmbH & Co. KG, Wuppertal since 03/2015 Chairperson of the Advisory Board of AiCuris Antiinfective Cures GmbH, Wuppertal Further board positions: E. Merck KG, Darmstadt, Germany (Member of the Board of Partners) 4SC AG, Martinsried Supervisory Board of the University Medical Center Bon
Research Interest
Business
